Clinical Trials Sponsored by Shanghai Cell Therapy Group Co.,Ltd

Total 111 results

Shanghai Cell Therapy Group Co.,Ltd

Recruiting

An Exploratory Study by Fast CAR T Cells

Solid Tumor

China
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells

Solid Tumor

China
Shanghai Cell Therapy Group Co.,Ltd

Not yet recruiting

The Exploratory Study on the Biological Function of Dendritic Cells In Vivo Supported by Nicotinamide Mononucleotide (Vital NAD)

Postoperative Prevention of Tumor

China
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors

Colorectal Cancer

China
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors

Solid Tumor

China
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

Solid Tumor

China
Shanghai Mengchao Cancer Hospital
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Solid Tumor

China
Shanghai Cell Therapy Group Co.,Ltd
Shanghai Mengchao Cancer Hospital

Not yet recruiting

The Exploratory Study on the Baseline Level of NAD+/NADH in Peripheral Blood Samples of Different Gender and Age Groups of Healthy Adults.

NAD+/NADH in Peripheral Blood Monitoring

China
Shanghai Cell Therapy Group Co.,Ltd
Shanghai Mengchao Cancer Hospital

Not yet recruiting

The Exploratory Study on the Nicotinamide Mononucleotide (Vital NAD ) to Promote the Rejuvenation of the Peripheral Blood Immune Cells of Adults.

Enhance Immune Function

China
Shanghai Mengchao Cancer Hospital
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

Study of Efficacy of BZ019 in Large B-cell Lymphoma

Large B-cell Lymphoma

China
Shanghai Cell Therapy Group Co.,Ltd
Shanghai 10th People's Hospital

Unknown

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Colorectal Cancer | Ovarian Cancer

China
Shanghai Cell Therapy Group Co.,Ltd
Shanghai Mengchao Cancer Hospital

Not yet recruiting

The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults

Hyperlipidemia | Sub-healthy | Toxic Metal Ions Accumulation

China
Wuhan Union Hospital, China
Shanghai Cell Therapy Group Co.,Ltd

Unknown

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Non-small-cell Lung Cancer | Mesothelioma

China
Sinobioway Cell Therapy Co., Ltd.

Unknown

CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma

Lymphoma

China
Sinobioway Cell Therapy Co., Ltd.

Unknown

Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer (EECLC)

Liver Neoplasms

China
Sinobioway Cell Therapy Co., Ltd.

Unknown

Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer (EECSC)

Stomach Neoplasms

China
Shanghai Cell Therapy Group Co.,Ltd
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting

Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors

Advanced Solid Tumor

China
Asia Cell Therapeutics (Shanghai) Co., Ltd.

Not yet recruiting

Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells in Patients With Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome
Asia Cell Therapeutics (Shanghai) Co., Ltd.

Not yet recruiting

Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis

Decompensated Liver Cirrhosis
Institute of Hematology & Blood Diseases Hospital
Shanghai Cell Therapy Engineering Technology Research Center Group Co., Ltd.

Unknown

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Transformed Lymphoma

China
Shanghai iCELL Biotechnology Co., Ltd, Shanghai...

Not yet recruiting

Safety and Efficacy Study of hAESCs Therapy for aGVHD (aGVHD，hAESCs)

GVHD,Acute
Sinobioway Cell Therapy Co., Ltd.
Jiangsu Cancer Institute & Hospital

Unknown

Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma (EECPL)

Lymphoma

China
Asia Cell Therapeutics (Shanghai) Co., Ltd.
RenJi Hospital

Not yet recruiting

Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis
Shanghai Unicar-Therapy Bio-medicine Technology...

Recruiting

CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

China
Shanghai East Hospital
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China

Recruiting

Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease

Idiopathic Parkinson's Disease

China
Shanghai East Hospital
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China

Completed

Stereotactic Transplantation of hAESCs for Parkinson's Disease

Parkinson's Disease

China
Xijing Hospital
Beijing GD Initiative Cell Therapy Technology Co., Ltd.

Not yet recruiting

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Melanoma
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's Firesorb BVS: FUTURE-III (FUTURE-III)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Coronary Disease | Percutaneous Coronary Intervention | Dual Antiplatelet Therapy | Drug Eluting Stent

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II (FUTURE-II)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke (SAFE-PROTECT)

Stroke | Atrial Fibrillation

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )

Coronary Heart Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Safety and Efficacy of Rotator Cuff Function Restoration Balloon in Irreparable Rotator Cuff Tear

Rotator Cuff Tears
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

Percutaneous Coronary Intervention | Drug-Eluting Stents | Tomography, Optical Coherence

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

The First-In-Man Pilot Study of Firehawk

Coronary Heart Disease
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial (FOCUS)

Coronary Heart Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation

Optical Coherence Tomography | Angiography | Intravascular Ultrasound

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment (T-P)

Coronary Artery Disease | Coronary Stenosis

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

A First-in-Man Study of the Firesorb BVS (FUTURE-I) (FUTURE-I)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)

Coronary Artery Disease

Denmark
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease (Firehawk_38)

Coronary Heart Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk Rapamycin Target Eluting Coronary Stent North American Trial (TARGET-IV_NA)

Coronary Artery Disease

United States, Denmark, Canada, Belgium, Netherlands
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI

Aortic Valve Stenosis | Aortic Valve Disease | Aortic Valve Calcification

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Recruiting

A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE) (LARGE-ONE)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Not yet recruiting

Trial for MicroPort's DCB

Coronary Artery In-stent Restenosis
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF)

Coronary Artery Disease

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial

Coronary Artery Disease

China
Shanghai Unicar-Therapy Bio-medicine Technology...

Recruiting

Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Relapsed or Refractory Non-Hodgkin's Lymphoma

China

Clinical Trials Sponsored by Shanghai Cell Therapy Group Co.,Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations